India’s Zydus Buys Laboratories Combix Of Spain For Generics Market
This article was originally published in PharmAsia News
Zydus Cadila of India said it has acquired the assets of Laboratories Combix of Spain, but did not disclose the purchase amount. A Zydus official said the takeover would help the firm establish itself as a global health care provider in addition to making generic drugs. The official said Zydus was counting on a rapidly growing market for generics in Spain, already considered the world's fifth-largest market for pharmaceuticals. Combix already has a portfolio of 17 molecules. (Click here for more
You may also be interested in...
NEW DELHI - Indian generic drug firm Zydus Cadila said a wholly-owned unit bought a 70 percent stake in South Africa's Simayla Pharmaceuticals of South Africa at an undisclosed price to expand market share in the cardiovascular, anti-infective, respiratory, gastrointestinal and women's healthcare segments
The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.
The pilot will allow at least a hundred device companies with 510(k)s under review this spring to test out the new industry submission-tracking dashboard.